Search the Community
Showing results for tags 'Neoadjuvant therapy'.
Good morning Members, For some of you that have followed my last post or not, here is the background info. My mom was diagnosed Stage 3A NSCLC. Her tumor is 6cm, 4.1x 3.8 x 5.8, located in the central upper left lobe and beginning to invade left main pulmonary artery. I was told that resection is possible following neoadjuvant therapy. I was given a choice of standard chemotherapy for three months OR 2 infusions of nivolumab as a trial for 4 weeks. I contemplated which first line therapy choice I would use for the last five days. However, I received a call and now was told that upon further review of the case, the team wants to move forward straight to surgery and do adjuvant chemotherapy afterwards due to fear of disease progression leaving my mom unresectable. I was not informed of what kind of resection is planned just yet. I’d like to know the risks/recovery expected with a resection of this size and location. How quickly must chemotherapy be initiated after a surgery? Is there a strong chance of hidden disease spreading as a result of surgery without having systemic chemo first? If members can weigh in with their thoughts and experiences, that would be great!